文献
J-GLOBAL ID:202202263331405752
整理番号:22A0890829
周術期チロフィバンによる強力な血小板抑制は急性冠動脈症候群患者におけるアテローム性動脈硬化症の進行を減衰させる可能性がある【JST・京大機械翻訳】
Potent platelet inhibition with peri-procedural tirofiban may attenuate progression of atherosclerosis in patients with acute coronary syndromes
著者 (7件):
Nakajima Akihiro
(Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA)
,
Araki Makoto
(Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA)
,
Kurihara Osamu
(Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA)
,
Lee Hang
(Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA)
,
Nakamura Sunao
(Interventional Cardiology Unit, New Tokyo Hospital, Chiba, Japan)
,
Jang Ik-Kyung
(Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA)
,
Jang Ik-Kyung
(Kyung Hee University, Seoul, Korea)
資料名:
Journal of Thrombosis and Thrombolysis
(Journal of Thrombosis and Thrombolysis)
巻:
53
号:
2
ページ:
241-248
発行年:
2022年
JST資料番号:
W4673A
ISSN:
0929-5305
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)